CareTrust REIT (NYSE:CTRE – Get Free Report) had its target price reduced by equities research analysts at UBS Group from $48.00 to $44.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s target price would suggest a potential upside of 20.43% from the stock’s current price.
Several other equities research analysts also recently commented on the stock. Royal Bank Of Canada restated a “sector perform” rating and issued a $43.00 target price on shares of CareTrust REIT in a research note on Monday, October 5th. Weiss Ratings cut shares of CareTrust REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Monday. Citigroup reissued a “market outperform” rating on shares of CareTrust REIT in a report on Tuesday. Huntington began coverage on shares of CareTrust REIT in a research report on Thursday, September 10th. They issued an “outperform” rating and a $44.00 price target on the stock. Finally, Cantor Fitzgerald boosted their price target on shares of CareTrust REIT from $42.00 to $43.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, CareTrust REIT currently has an average rating of “Moderate Buy” and a consensus target price of $43.92.
Check Out Our Latest Stock Report on CareTrust REIT
CareTrust REIT Price Performance
CareTrust REIT (NYSE:CTRE – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.51 EPS for the quarter, hitting the consensus estimate of $0.51. CareTrust REIT had a return on equity of 8.52% and a net margin of 62.19%. The business had revenue of $161.35 million during the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. On average, sell-side analysts predict that CareTrust REIT will post 2.07 EPS for the current fiscal year.
Institutional Trading of CareTrust REIT
Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in CareTrust REIT during the second quarter valued at approximately $1,643,290,000. Deutsche Bank AG bought a new stake in CareTrust REIT in the second quarter valued at approximately $143,963,000. Bank of New York Mellon Corp acquired a new stake in CareTrust REIT in the second quarter worth $102,162,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in CareTrust REIT by 35,170.9% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company’s stock worth $56,970,000 after purchasing an additional 1,407,893 shares during the period. Finally, Legal & General Group Plc acquired a new stake in CareTrust REIT in the second quarter worth $46,866,000. 87.77% of the stock is currently owned by institutional investors and hedge funds.
CareTrust REIT Company Profile
CareTrust REIT, Inc is a real estate investment trust that owns, acquires, develops, and leases healthcare-related properties. Its portfolio is primarily focused on skilled nursing facilities, assisted living communities, and other post-acute care properties operated by third-party healthcare providers.
The company generally leases its properties under long-term agreements, including triple-net leases, under which tenants are typically responsible for property-level expenses such as taxes, insurance, and maintenance.
Further Reading
- Five stocks we like better than CareTrust REIT
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for CareTrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.
